Clinical Trial Update: The Safety and Dose Response Relationship of Ulinastatin for Acute Respiratory Distress Syndrome(ARDS) [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial assesses the safety and dose-response relationship of ulinastatin for acute respiratory distress syndrome.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Respiratory Distress Syndrome

Drugs mentioned

• Ulinastatin (ulinastatin)

Snippet

Sponsor: Techpool Bio-Pharma Co., Ltd. | Conditions: Acute Respiratory Distress Syndrome | Phase 2 | Status: UNKNOWN